ACADIA Q1 2026 slides: revenue rises 11% despite earnings miss
Introduction & Market Context ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) presented its first quarter 2026 financial results on May 6, 2026, revealing a complex picture of commercial momentum offset by near-term profitability challenges. While the company delivered 11% year-over-year revenue growth to $268.1 million, earnings per share of $0.02 fell significantly short of the $0.05 analyst forecast,…